MediciNova (MNOV) Short Interest Ratio & Short Volume $1.66 -0.02 (-1.19%) (As of 11/1/2024 ET) Add Compare Share Share Short Interest Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends MediciNova Short Interest DataMediciNova (MNOV) has a short interest of 198,200 shares, representing 0.43% of the float (the number of shares available for trading by the public). This marks a 0.71% increase in short interest from the previous month. The short interest ratio (days to cover) is 5.2, indicating that it would take 5.2 days of the average trading volume of 38,655 shares to cover all short positions.Current Short Interest198,200 sharesPrevious Short Interest196,800 sharesChange Vs. Previous Month+0.71%Dollar Volume Sold Short$358,742.00Short Interest Ratio5.2 Days to CoverLast Record DateOctober 15, 2024Outstanding Shares49,050,000 sharesFloat Size46,480,000 sharesShort Percent of Float0.43%Today's Trading Volume36,477 sharesAverage Trading Volume38,655 sharesToday's Volume Vs. Average94% Short Selling MediciNova? Sign up to receive the latest short interest report for MediciNova and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartMNOV Short Interest Over TimeMNOV Days to Cover Over TimeMNOV Percentage of Float Shorted Over Time Ad Chaikin AnalyticsSell NVDA Now?Guess who's selling NVDA next The most successful hedge fund in history quietly sold 500,000 shares. Here's what that means for your money. Billionaire Wall Street investors are quietly offloading millions of shares. What do they know that you don't? It's arguably the most popular stock in the world. Now, one 50-year Wall Street legend says its day in the sun could finally be coming to an end. Last year, he warned of two stocks that went on to crash 60%.Now he's just issued a warning for the most popular stock in the world: Nvidia (NVDA). MediciNova Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 10/15/2024198,200 shares $358,742.00 +0.7%0.4%5.2 $1.81 9/30/2024196,800 shares $413,280.00 -12.4%0.4%5.2 $2.10 9/15/2024224,600 shares $408,772.00 +19.3%0.5%5.7 $1.82 8/31/2024188,200 shares $282,300.00 +104.3%0.4%4.6 $1.50 8/15/202492,100 shares $106,836.00 -2.0%0.2%4.4 $1.16 7/31/202494,000 shares $125,960.00 -13.8%0.2%4.2 $1.34 Get the Latest News and Ratings for MNOV and Related StocksEnter your email address below to receive the latest news and analysts' ratings for MediciNova and its competitors with MarketBeat's FREE daily newsletter. 7/15/2024109,000 shares $154,780.00 +6.0%0.2%5 $1.42 6/30/2024102,800 shares $148,032.00 -7.1%0.2%4.2 $1.44 6/15/2024110,700 shares $147,231.00 -18.4%0.2%3.2 $1.33 5/31/2024135,600 shares $184,416.00 -14.5%0.3%4.3 $1.36 5/15/2024158,600 shares $233,142.00 -25.5%0.3%4.4 $1.47 4/30/2024212,900 shares $274,641.00 -13.8%0.5%4.4 $1.29 4/15/2024247,000 shares $380,380.00 -26.0%0.5%5 $1.54 3/31/2024333,600 shares $483,720.00 +2.3%0.7%6.2 $1.45 3/15/2024326,000 shares $423,800.00 -3.5%0.7%5.6 $1.30 2/29/2024337,800 shares $456,030.00 +34.5%0.7%5.7 $1.35 2/15/2024251,200 shares $339,120.00 +3.3%0.5%4.1 $1.35 1/31/2024243,100 shares $342,771.00 -24.8%0.5%2.1 $1.41 1/15/2024323,400 shares $485,100.00 -8.3%0.7%2.8 $1.50 12/31/2023352,600 shares $528,900.00 -6.5%0.8%3.2 $1.50 12/15/2023377,100 shares $588,276.00 +0.5%0.8%3.6 $1.56 11/30/2023375,100 shares $678,931.00 +57.7%0.8%3.8 $1.81 11/15/2023237,800 shares $418,528.00 -2.3%0.5%2.5 $1.76 10/31/2023243,400 shares $464,894.00 -20.7%0.5%11.6 $1.91 10/15/2023307,000 shares $614,000.00 -16.1%0.7%14.3 $2.00 9/30/2023365,700 shares $764,313.00 -1.8%0.8%17.3 $2.09 9/15/2023372,400 shares $759,696.00 +0.8%0.8%19.8 $2.04 8/31/2023369,500 shares $901,580.00 +0.4%0.8%18.1 $2.44 8/15/2023368,100 shares $850,311.00 -0.3%0.8%18.9 $2.31 7/31/2023369,300 shares $878,934.00 -2.1%0.8%20.6 $2.38 7/15/2023377,300 shares $965,888.00 +0.7%0.8%20.6 $2.56 6/30/2023374,800 shares $862,040.00 +5.6%0.8%18.3 $2.30 6/15/2023354,800 shares $819,588.00 +4.7%0.8%18.1 $2.31 5/31/2023339,000 shares $728,850.00 -4.6%0.7%17.6 $2.15 5/15/2023355,400 shares $783,657.00 +1.6%0.8%17.9 $2.21 4/30/2023349,700 shares $737,867.00 -0.6%0.8%16.7 $2.11 4/15/2023351,800 shares $809,140.00 +3.9%0.8%16.4 $2.30 3/31/2023338,700 shares $731,592.00 -1.1%0.7%13.3 $2.16 3/15/2023342,600 shares $719,460.00 -5.4%0.7%7.5 $2.10 2/28/2023362,100 shares $796,620.00 -0.2%0.8%5.4 $2.20Sell NVDA Now? (Ad)Guess who's selling NVDA next The most successful hedge fund in history quietly sold 500,000 shares. Here's what that means for your money. Billionaire Wall Street investors are quietly offloading millions of shares. What do they know that you don't? It's arguably the most popular stock in the world. Now, one 50-year Wall Street legend says its day in the sun could finally be coming to an end. Last year, he warned of two stocks that went on to crash 60%.Now he's just issued a warning for the most popular stock in the world: Nvidia (NVDA). 2/15/2023362,800 shares $838,068.00 -3.1%0.8%4.9 $2.31 1/31/2023374,500 shares $895,055.00 -0.9%0.8%4.7 $2.39 1/15/2023377,800 shares $936,944.00 -3.8%0.8%4.6 $2.48 12/30/2022392,700 shares $805,035.00 -25.7%0.9%4.8 $2.05 12/15/2022528,700 shares $1.24 million +20.9%1.1%7.4 $2.35 11/30/2022437,200 shares $1.15 million -34.7%0.9%10.1 $2.64 11/15/2022669,300 shares $1.44 million -17.6%1.4%18.5 $2.15 10/31/2022812,400 shares $1.66 million +0.1%1.8%26.9 $2.04 10/15/2022811,600 shares $1.62 million -15.6%1.8%30.2 $1.99 9/30/2022961,000 shares $2.09 million -11.8%2.1%36 $2.17 9/15/20221,090,000 shares $2.40 million -3.5%2.4%45.4 $2.20 8/31/20221,130,000 shares $2.41 million -1.7%2.4%48.3 $2.13 8/15/20221,150,000 shares $2.85 million No Change2.5%45.6 $2.48 7/31/20221,150,000 shares $2.66 million -4.2%2.4%42.6 $2.31 7/15/20221,200,000 shares $2.86 million -0.8%2.5%41.4 $2.38 6/30/20221,210,000 shares $3.06 million -2.4%2.5%34 $2.53 6/15/20221,240,000 shares $3.16 million -0.8%3.5%28.8 $2.55 5/31/20221,250,000 shares $3.04 million +0.8%2.7%28.3 $2.43 5/15/20221,240,000 shares $2.99 million -7.5%2.7%26.1 $2.41 4/30/20221,340,000 shares $3.58 million -3.6%2.9%26.3 $2.67 4/15/20221,390,000 shares $4.25 million -4.1%3.0%14.6 $3.06 3/31/20221,450,000 shares $3.87 million No Change3.1%14.3 $2.67 3/15/20221,450,000 shares $3.34 million -13.7%3.1%12.3 $2.30 2/28/20221,680,000 shares $4.02 million -2.9%3.6%10.7 $2.39 2/15/20221,730,000 shares $4.26 million +10.9%3.7%3.2 $2.46 1/31/20221,560,000 shares $3.78 million -12.4%3.4%2.9 $2.42 1/15/20221,780,000 shares $4.49 million -1.1%3.8%3.5 $2.52 12/31/20211,800,000 shares $4.82 million -4.8%3.9%3.6 $2.68 12/15/20211,890,000 shares $5.42 million -17.5%4.1%3.8 $2.87 11/30/20212,290,000 shares $7.51 million +30.1%4.9%4.9 $3.28 11/15/20211,760,000 shares $6.21 million +2.9%3.8%4.1 $3.53 10/29/20211,710,000 shares $5.75 million +0.6%3.7%14.3 $3.36 10/15/20211,700,000 shares $6.49 million -1.7%3.7%13.9 $3.82 9/30/20211,730,000 shares $6.56 million -9.0%3.7%10.8 $3.79 9/15/20211,900,000 shares $7.58 million -0.5%4.1%5.7 $3.99 8/31/20211,910,000 shares $7.47 million -5.9%4.1%2.3 $3.91 8/13/20212,030,000 shares $7.13 million -1.9%4.4%2.4 $3.51 7/30/20212,070,000 shares $7.51 million -2.8%4.5%2.5 $3.63 7/15/20212,130,000 shares $7.88 million -9.8%4.6%2.4 $3.70 6/30/20212,360,000 shares $10.03 million -40.1%5.1%2.6 $4.25 6/15/20213,940,000 shares $16.15 million +1.0%8.5%5 $4.10 5/28/20213,900,000 shares $16.46 million -0.5%8.4%8.3 $4.22 5/14/20213,920,000 shares $15.88 million +6.2%N/A4.2 $4.05 4/30/20213,690,000 shares $17.42 million +17.9%N/A4 $4.72 4/15/20213,130,000 shares $14.49 million +1.6%N/A3.5 $4.63 3/31/20213,080,000 shares $15.25 million -2.2%N/A3.5 $4.95 3/15/20213,150,000 shares $18.99 million +36.4%N/A3.6 $6.03 2/26/20212,310,000 shares $12.57 million +3.1%N/A10.4 $5.44 2/12/20212,240,000 shares $14.29 million -17.7%N/A11.1 $6.38 1/29/20212,720,000 shares $15.83 million -2.2%6.7%12.9 $5.82Sell NVDA Now? (Ad)Guess who's selling NVDA next The most successful hedge fund in history quietly sold 500,000 shares. Here's what that means for your money. Billionaire Wall Street investors are quietly offloading millions of shares. What do they know that you don't? It's arguably the most popular stock in the world. Now, one 50-year Wall Street legend says its day in the sun could finally be coming to an end. Last year, he warned of two stocks that went on to crash 60%.Now he's just issued a warning for the most popular stock in the world: Nvidia (NVDA). 1/15/20212,780,000 shares $15.90 million -4.1%6.9%13.3 $5.72 12/31/20202,900,000 shares $14.99 million +12.8%7.2%15.3 $5.17 12/15/20202,570,000 shares $15.42 million -7.9%6.4%11.5 $6.00 11/30/20202,790,000 shares $16.66 million -15.2%6.9%6 $5.97 11/15/20203,290,000 shares $19.87 million +2.2%8.2%7 $6.04 10/30/20203,220,000 shares $18.39 million +2.9%8.0%6.7 $5.71 10/15/20203,130,000 shares $16.46 million -7.7%7.9%1.6 $5.26 9/30/20203,390,000 shares $17.76 million +42.4%8.5%1.7 $5.24 9/15/20202,380,000 shares $13.85 million +3.9%6.1%1.2 $5.82 8/31/20202,290,000 shares $12.00 million -2.6%5.9%1.4 $5.24 8/14/20202,350,000 shares $14.24 million -19.2%6.3%1.5 $6.06 7/31/20202,910,000 shares $18.10 million +21.8%7.8%1.8 $6.22 7/15/20202,390,000 shares $12.74 million +3.5%6.5%18.5 $5.33 6/30/20202,310,000 shares $12.57 million +6.9%6.2%13.1 $5.44 6/15/20202,160,000 shares $13.74 million -4.9%5.8%13.3 $6.36 5/29/20202,270,000 shares $12.12 million +1.8%6.1%12.6 $5.34 5/15/20202,230,000 shares $12.73 million -1.3%6.0%12 $5.71 4/30/20202,260,000 shares $11.64 million -6.2%6.1%12.5 $5.15 4/15/20202,410,000 shares $13.77 million -2.0%6.5%14.1 $5.72 3/31/20202,460,000 shares $13.41 million -16.1%6.6%17.3 $5.45 3/13/20202,933,100 shares $17.86 million +2.2%7.9%20.4 $6.09 2/28/20202,870,000 shares $8.32 million -2.7%7.8%28.8 $2.90 2/14/20202,950,000 shares $10.59 million -1.7%8.0%29.7 $3.59 1/31/20203,000,000 shares $13.68 million -0.3%8.1%31.9 $4.56 1/15/20203,010,000 shares $18.54 million +2.4%8.2%30.6 $6.16 12/31/20192,940,000 shares $18.67 million -8.1%8.0%27.3 $6.35 MNOV Short Interest - Frequently Asked Questions What is MediciNova's current short interest? Short interest is the volume of MediciNova shares that have been sold short but have not yet been covered or closed out. As of October 15th, investors have sold 198,200 shares of MNOV short. 0.43% of MediciNova's shares are currently sold short. Learn More on MediciNova's current short interest. What is a good short interest ratio for MediciNova? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. MNOV shares currently have a short interest ratio of 5.0. Learn More on MediciNova's short interest ratio. What is a good short interest percentage for MediciNova? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.43% of MediciNova's floating shares are currently sold short. Is MediciNova's short interest increasing or decreasing? MediciNova saw a increase in short interest in October. As of October 15th, there was short interest totaling 198,200 shares, an increase of 0.7% from the previous total of 196,800 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is MediciNova's float size? MediciNova currently has issued a total of 49,050,000 shares. Some of MediciNova's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. MediciNova currently has a public float of 46,480,000 shares. How does MediciNova's short interest compare to its competitors? 0.43% of MediciNova's shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to MediciNova: Verrica Pharmaceuticals Inc. (17.38%), Kezar Life Sciences, Inc. (16.31%), Hookipa Pharma Inc (0.34%), VYNE Therapeutics Inc. (0.39%), NextCure, Inc. (0.35%), Verastem, Inc. (6.65%), Aldeyra Therapeutics, Inc (5.92%), Jasper Therapeutics, Inc. (15.63%), Lexeo Therapeutics, Inc. (9.37%), biote Corp. (2.95%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.14 billion), AppLovin Co. ($3.15 billion), Paychex, Inc. ($2.69 billion), Nu Holdings Ltd. ($2.48 billion), Cencora, Inc. ($2.24 billion), International Paper ($2.04 billion), Tractor Supply ($1.96 billion), Coinbase Global, Inc. ($1.93 billion), Moderna, Inc. ($1.91 billion), and SoFi Technologies, Inc. ($1.84 billion). View all of the most shorted stocks. What does it mean to sell short MediciNova stock? Short selling MNOV is an investing strategy that aims to generate trading profit from MediciNova as its price is falling. MNOV shares are trading down $0.02 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against MediciNova? A short squeeze for MediciNova occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of MNOV, which in turn drives the price of the stock up even further. How often is MediciNova's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including MNOV, twice per month. The most recent reporting period available is October, 15 2024. More Short Interest Resources from MarketBeat Related Companies Verrica Pharmaceuticals Short Interest Data Kezar Life Sciences Short Interest Data Hookipa Pharma Short Interest Data VYNE Therapeutics Short Interest Data NextCure Short Interest Data Verastem Short Interest Data Aldeyra Therapeutics Short Interest Data Jasper Therapeutics Short Interest Data Lexeo Therapeutics Short Interest Data biote Short Interest Data Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:MNOV) was last updated on 11/2/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredEx WH Advisor Who Predicted Biden Leaving Race Makes Startling New PredictionFormer advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | SponsoredSell NVDA Now?Guess who's selling NVDA next The most successful hedge fund in history quietly sold 500,000 shares. Here's...Chaikin Analytics | SponsoredMarket "Famine" ComingMarket Wizard Larry Benedict accurately predicted that all indexes would be negative in 2022... He predicte...Opportunistic Trader | SponsoredBlackrock’s Sending THIS Crypto Higher on PurposeIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredNvidia warning urgentI thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredNothing can stop this gold rallyAfter what's felt like nearly a decade of disappointing gains, gold is stronger than ever and continues to hit...Stansberry Research | SponsoredWall St. Legend: Millions of Americans About to Fall Out of the 1%Wall Street insider reveals the financial tidal wave about to knock millions of Americans out of the One Perce...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding MediciNova, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share MediciNova With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
